School of Medicine


Showing 51-100 of 101 Results

  • Stephen Richmond

    Stephen Richmond

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Stephen Richmond (he/him/his) is a family physician, educator, and health justice advocate with specific interest in racial equity in medicine. He currently serves as a clinical assistant professor of medicine in the Division of Primary Care & Population Health (PCPH) in the Stanford Department of Medicine. He completed his A.S. at Solano Community College, B.A. in Molecular & Cell Biology at UC Berkeley, M.P.H. at Harvard T.H. Chan School of Public Health, and his M.D. at David Geffen School of Medicine, UCLA. He is a graduate of the UCSF-San Francisco General Hospital Family & Community Medicine Residency Program.

    As a clinician, Dr. Richmond cares for individuals of all ages with a wide range of acute and chronic illnesses. He is especially passionate about providing high quality, evidenced-based care to underserved communities of color. As a researcher and educator, his interests broadly involve the intersection of race, racism, and medicine, with current projects focused on applications of Critical Race Theory to medical education and clinical care. He currently serves as the faculty director for the REACH Health Equity Scholarly Concentration within the school of Medicine and the Diversity, Equity, & Inclusion Curriculum Lead within the PCPH Division.

    Beyond Stanford, Dr. Richmond is involved in many ongoing advocacy efforts aimed at achieving health equity through individual and structural-level change. Dr. Richmond has received multiple teaching awards for his work in the space of equity, inclusion & anti-oppression in medicine, and is a routine presenter and consultant in these areas.

  • Huijun Ring

    Huijun Ring

    Adjunct Professor, Primary Care and Population Health

    BioDr. Huijun Ring received her PhD in molecular biology and genetics from Cornell University and completed her post-doctoral medical genetics training at Stanford University School of Medicine. She is a clinical molecular geneticist and board-certified by the American Board of Medical Genetics.

    Dr. Ring is an experienced biotech entrepreneur and executive. Previously she worked at Incyte Pharmaceuticals and DNA Direct in Silicon Valley. She was the founder and CEO of iDNA Inc, a precision medicine company. iDNA Inc. was named as one of the fastest growing technology companies in China by Deloitte and was acquired by a public company. She has also cofounded and advised several biotech startups in Silicon Valley and mentored many first-time entrepreneurs.

    Currently, Dr. Ring is an Adjunct Professor in the Department of Medicine at Stanford University, specializing in genomic medicine, AI health and longevity research. She mentors students from the Stanford Graduate School of Business, Knight-Hennessy Scholars, and junior women faculty in science and medicine through the Stanford University Faculty Development Office. Additionally, Dr. Ring teaches the course "Science and History of Traditional Chinese Medicine" and serves as a faculty advisor for the Stanford iGEM (International Genetically Engineered Machine) team. Dr. Ring is co-founder of Stanford Hub for AI Wellbeing and Longevity.

  • Sonia Rios-Ventura

    Sonia Rios-Ventura

    Family Health Navigator, Medicine - Med/Oncology

    BioSonia Rios-Ventura is a clinical research coordinator associate for the Stanford School of Medicine, department of Cancer Genetics and Genomics. She received her B.A. in anthropology and intensive sociology from the University of California Santa Cruz.

    She is also the family health navigator for the Genetic Information and Family Testing (GIFT) Study. GIFT's mission is to help families beat cancer. It aims to save lives through education and communication about cancer risk and prevention in families. When someone learns they have a genetic mutation that increases their risk for cancer, it means their family members might also be at risk. For too long, the difficult job of talking about family cancer risk has fallen to the cancer patients alone. GIFT is here to make it easier for people to share this important information and give family members an easy way to get genetic testing to learn about their personal cancer risk. GIFT is an online program developed by cancer patients, family members, and doctors that offers a new way to, 1. Share life-saving information about family cancer risk and ways to lower that risk, 2.Connect interested family members to easy, at-home genetic testing.

  • Norman Rizk

    Norman Rizk

    Berthold and Belle N. Guggenhime Professor, Emeritus

    Current Research and Scholarly InterestsI am interested in the prevention and control of critical care-related illnesses and complications, including ventilator-associated pneumonia, spread of nosocomial infections, and prognosis of multiple organ system failure in intensive care units. Infections and complications of therapy in immunocompromised hosts, including effects of chemotherapy and hematopoetic stem cell transplants is another interest.

  • Jennifer Robinson

    Jennifer Robinson

    Associate Director, Medicine - Med/Stanford Prevention Research Center

    Current Role at StanfordAssociate Director, Nutrition Studies Group

  • Thomas Robinson

    Thomas Robinson

    The Irving Schulman, M.D. Professor of Child Health, Professor of Medicine (Stanford Prevention Research Center) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Robinson originated the solution-oriented research paradigm and directs the Stanford Solutions Science Lab. He is known for his pioneering obesity prevention and treatment research, including the concept of stealth interventions. His research applies social cognitive models of behavior change to behavioral, social, environmental and policy interventions for children and families in real world settings, making the results relevant for informing clinical and public health practice and policy.

  • William H. Robinson, MD PhD

    William H. Robinson, MD PhD

    James W. Raitt, M.D. Professor

    Current Research and Scholarly InterestsOur lab investigates the molecular mechanisms of and develops therapies to treat autoimmune and rheumatic diseases, with a focus on rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and osteoarthritis.

    The overriding objectives of our laboratory are:
    1. To elucidate the mechanisms underlying autoimmune and rheumatic diseases.
    2. To investigate the role of innate immune inflammation in osteoarthritis.
    3. To develop novel diagnostics and therapeutics

  • Stanley G. Rockson, MD

    Stanley G. Rockson, MD

    Allan and Tina Neill Professor of Lymphatic Research and Medicine

    Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.

  • Fatima Rodriguez

    Fatima Rodriguez

    Associate Professor of Medicine (Cardiovascular Medicine)

    BioFatima Rodriguez, MD, MPH is an Associate Professor in Cardiovascular Medicine and (by courtesy) the Stanford Prevention Research Center. Dr. Rodriguez earned her medical degree from Harvard Medical School and her MPH from the Harvard School of Public Health. She then completed internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford University. She currently serves as the Section Chief of Preventive Cardiology. Dr. Rodriguez specializes in cardiovascular disease prevention, inherited lipid disorders, and cardiovascular risk assessment in high-risk populations.

    Dr. Rodriguez’s research includes a range of topics around racial, ethnic, and gender disparities in cardiovascular disease prevention, developing novel interventions to address disparities, and opportunistic screening of coronary artery disease.

  • Stephan Rogalla, M.D. PhD

    Stephan Rogalla, M.D. PhD

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsThe research interest of myself and my lab are in the field of early cancer detection using targeted molecular spies to highlight (pre)cancerous lesions. We as well aim to improve precision medicine in autoimmune disorders like inflammatory bowel disease and oncology.

  • Albert "A.J." Rogers, MD, MBA

    Albert "A.J." Rogers, MD, MBA

    Instructor, Medicine - Cardiovascular Medicine

    BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is also an instructor of medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.

    As a clinical cardiac electrophysiologist, Dr. Rogers’ training includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). His expertise includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.

    Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.

    As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 10 years of experience with medical technology innovation and development.

    Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He is also a peer reviewer for multiple prestigious journals, including Heart Rhythm, The Lancet: Digital Health, the Journal of the American College of Cardiology: Clinical Electrophysiology, and Frontiers in Physiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society.

  • Angela Rogers

    Angela Rogers

    Associate Professor of Medicine (Pulmonary and Critical Care)

    Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.

  • Nidhi Rohatgi, MD MS

    Nidhi Rohatgi, MD MS

    Clinical Professor, Medicine
    Clinical Professor (By courtesy), Neurosurgery
    Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain Medicine

    BioNidhi Rohatgi, MD, MS, SFHM is a Clinical Professor of Medicine and by courtesy, of Neurosurgery, Anesthesiology, Perioperative and Pain Medicine. She is a Surgical Co-management Hospitalist (Neurosurgery, Orthopedic surgery, and ENT) in the Division of Hospital Medicine at Stanford University School of Medicine and served as the Chief for Surgical Co-management till 2024. She manages medical co-morbidities and strives to prevent medical complications in post-surgical patients in the hospital setting. Dr. Rohatgi has led several quality improvement and clinical research studies and is passionate about finding innovative, cost-efficient and sustainable solutions in healthcare. She serves as an investigator in NIH and industry sponsored clinical trials and was the Director of Clinical Research (Palo Alto) in the Division of Hospital Medicine. She is Affiliated Faculty at the Center for Artificial Intelligence in Medicine and Imaging at Stanford University and Stanford Center for Digital Health. She is an invited speaker at national and international meetings and serves on several national committees. She is the recipient of local, national, and international awards for her work as a clinician, educator, and researcher. Dr. Rohatgi is a strong advocate for patient experience and serves as the Medical Director for the Clinical Advice Services at Stanford Medicine.

  • Rajat Rohatgi

    Rajat Rohatgi

    Professor of Biochemistry and of Medicine (Oncology)

    Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.

  • Dana Nirel Romalis

    Dana Nirel Romalis

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDana Romalis has been a board certified Family Medicine physician since 2004. She enjoys taking care of families throughout all phases of life. Special interests include teaching, collaborative care, preventative medicine, behavioral change, and reproductive and adolescent health. Since 2017, she has been a primary care provider at the Life Connections Health Center in San Jose, caring for Cisco employees and their families.

    She was born and raised in Vancouver, Canada, where she also attended medical school at the University of British Columbia. As an undergraduate at Brandeis University, she double majored in Neuroscience and Psychology, and was captain of the women’s varsity diving team. She did her residency at Montefiore Medical Center’s Residency Program of Social Medicine in the Bronx, NY.

    Prior to joining Stanford’s primary care division in 2017, she worked for 10 years as a physician at Santa Clara Valley Medical Center on their interdisciplinary Valley Homeless Healthcare Program. She is committed to comprehensive and compassionate care for all.

    In her spare time, she enjoys spending time with her husband and 2 teenagers, reading, hiking, biking, and volunteering in her community.

  • Lisa Goldman Rosas

    Lisa Goldman Rosas

    Assistant Professor (Research) of Epidemiology and Population Health and of Medicine (Primary Care and Population Health)

    BioLisa Goldman Rosas, PhD MPH is an Assistant Professor in the Department of Epidemiology and Population Health and the Department of Medicine, Division of Primary Care and Population Health at Stanford School of Medicine. An epidemiologist by training, Dr. Goldman Rosas’ research focuses on addressing disparities in chronic diseases such as diabetes, heart disease, depression, and cancer among racial/ethnic minority families. This research features rigorous quantitative and qualitative methodologies, participatory qualitative approaches, and shared leadership with patient and community partners. She is passionate about integrating patients, caregivers, community organizations, and other key stakeholders in the research process in order to affect the greatest improvements in health and well-being. As a reflection of this passion, Dr. Goldman Rosas serves as the Faculty Director for the School of Medicine Office of Community Engagement, Co-Director of Community-Engaged Research for the Office of Cancer Health Equity, and Director of the Outreach, Recruitment and Engagement Core for the Alzheimer's Disease Research Center. In these roles, she supports other faculty and patient and community partners to develop sustainable and meaningful partnerships to support transformative research. In addition to research, she teaches at the undergraduate and graduate levels and has a special focus on increasing diversity in biomedical research.

  • Glenn Rosen

    Glenn Rosen

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Emeritus

    Current Research and Scholarly InterestsOur laboratory examines apoptotic and cell signaling pathways in cancer and lung disease. We are studying signaling pathways that regulate oxidative stress responses and cancer cell growth. Part of these studies focus on analysis of non-canonical transcription regulatory functions of the TERC and Tert components of telomerase in lung disease and cancer.

  • Larissa Roux MD PhD

    Larissa Roux MD PhD

    Adjunct Professor, Primary Care and Population Health

    BioLarissa Roux is a sport medicine physician and health economist. She completed medical school at the University of Alberta, and followed this with residency training in family medicine and a fellowship in primary care sport medicine at the University of Calgary, as well as advanced training in lifestyle medicine. She combined her clinical training with a master’s in public health at Harvard, and a PhD in health economics at the University of Calgary. Her interest in public health and health policy resulted in a post-doctoral fellowship at the US Centers for Disease Control, in Atlanta in the Division of Nutrition and Physical Activity. Although she has deeply enjoyed working with athletes and dancers, her main clinical interest has been in the optimization of human performance in patients with chronic conditions, including obesity, arthritis, and trauma. Her academic and health policy work has focused on the economic evaluation of competing therapies for obesity, and population-level physical activity promotion strategies in the US and around the world. Larissa's interest in data science and technology applications in global health contributed to an ongoing health information technology venture. She believes that innovative, tailored, multidisciplinary, and multimodal approaches to chronic disease have transformative potential in human health.

  • Corey Rovzar

    Corey Rovzar

    Postdoctoral Scholar, SCRDP/ Heart Disease Prevention

    Current Research and Scholarly InterestsEnhancing human movement through scalable, remotely delivered physical activity interventions, remote assessment and monitoring of human movement, health technology development, fall prevention, aging, digital balance assessment, improving access to health and healthcare, increasing healthspan, lifestyle medicine

  • Mohana Roy, MD

    Mohana Roy, MD

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Roy is a medical oncologist and a clinical assistant professor in the Stanford University School of Medicine Department of Medicine, Division of Medical Oncology. She has expertise in Lung and Thoracic cancers, but with a broad clinical interest in oncology.

    Dr. Roy became an oncologist because of her passion for patient care. She is committed to being a clinician and is focused on improving the patient experience, given how the complex process of getting cancer care can be made a bit more seamless. She is the Associate Medical Director for Quality at Stanford Cancer Center from 2022.

    She had led major efforts in the cancer program including starting standardized discharge follow up for patients after hospitalization, starting same day clinical care at the cancer center, and starting the Cancer Diagnostic Clinic. The Cancer Diagnostic Clinic aims to improve wait times to see an oncology team and is for patients with an unclear diagnosis of cancer but with suspected imaging concerns or atypical pathology. This clinic also includes patients who have a carcinoma of unknown primary (CUP).

    Her research interests include access to clinical trials, quality improvement and improving care delivery. In that effort, she has published on work regarding patient reported outcomes (PROs), through distress screening with the Stanford Medicine Cancer Center, and in care for patient with limited English proficiency.

    Dr. Roy received her medical degree from Albert Einstein College of Medicine, and then completed residency training at Beth Israel Deaconess Medical Center. She then completed fellowship training in Hematology and Oncology at Stanford, where she was chief fellow.

  • Michael Royer

    Michael Royer

    Postdoctoral Scholar, SCRDP/ Heart Disease Prevention

    Current Research and Scholarly InterestsDr. Royer's research interests include food insecurity, eating behaviors, and physical activity. His research primarily aims to remove barriers hindering individuals from accessing healthy food. Dr. Royer seeks to advance public health by sustainably promoting healthy eating and food security through innovative and evidence-based research approaches. Through his research, he is motivated to promote food security, healthy eating, and physical activity toward the prevention of chronic disease.

  • Michael Rubin

    Michael Rubin

    Adjunct Professor, Medicine

    BioMichael P. Rubin, MD, PhD is the Founder and CEO of Northpond Ventures, a multi-billion dollar science driven venture capital firm. Northpond is based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Dr. Rubin has been involved in investing in and developing over 100 startups, in a broad array of disciplines, including medicine, technology, financial services, and global consumer. Dr. Rubin’s experience spans engineering, medicine, surgery, venture capital, and entrepreneurship. Dr. Rubin also holds academic appointments at Harvard and MIT.

  • Peter Rudd, MD

    Peter Rudd, MD

    Professor of Medicine (General Internal Medicine) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsQuality improvement efforts seek to make medical care the “best it can be” rather than merely “good enough” to avoid censure. Focus on improving the average performance usually produces more net benefit than eliminating outliers, often by simplification, standardization, and specification. We have worked with electronic medication monitors, clinical databases, and computerized order entry systems for better clinical outcomes and trained clinicians for professionalism and accountability.

  • Stephen Ruoss

    Stephen Ruoss

    Professor of Medicine (Pulmonary and Critical Care)

    Current Research and Scholarly InterestsWe have an active collaborative project examining basic and clinical aspects of non-tuberculous mycobacterial lung infection in non-immune compromised adults. Studies have examined possible cellular immune mechanisms for increased susceptibility to these infections, and are also investigating aspects of optimal diagnosis and treatment. In addition, a clinical and translational research program is investigating the causes and genetic factors underlying the evolution of bronchiectasis.